Trust the Science Against the COVID Vaxx
Trust the Science Against Covid “Vaccines”
By: Sean Barker
6 May 2022
Denial can be a thick and dangerous thing. Those of us committed to various efforts to wake up the sleeping masses – including through the #SaveTheVaxxed movement – meet endless frustrations at every turn, rooted in denial and delusional thinking. People in this generation have been so inundated with propaganda that they no longer have an inner compass pointing them toward the truth. Or, maybe it’s still there – just buried really deeply.
Linguistic-based mind control programming is a huge part of how the elite keep the masses asleep. For 2 years now, those who watch too much television have been programmed with an insidious moniker, “Trust the Science.” Insidious indeed, because they never actually showed you the science that they spoke of – whether in regard to Covid or the vaxx. Rather, they used classical behavioral conditioning to program your subconscious mind to associate “trust” and “science” with the ilk of Anthony Fauci – the Josef Mengele of our time.
They did not want you thinking; they only wanted you to react. This is the opposite of what it means to truly trust science. Scientists seek to falsify their assumptions, not to confirm them. Scientists do not wed their face and reputations to false and unsubstantiated claims. Scientists tell you when they have conscripted you to their experiments – per industry ethics and laws that govern them. Scientists practice informed consent – meaning, when all the animals die in a clinical trial, they warn the people who sign up to participate in the human trials before administering the intervention. Real scientists would not dare subject 1 billion+ people to an untested injectable drug without an appropriately scaled and representative sample trial first.
These people are not scientists, and the talking points they trained you to swallow, believe, and repeat have nothing whatsoever to do with science. These people are genocidaires – and they have trained you to be their useful idiots.
Fortunately, we do have a plethora of real scientists still operating in the world today. Now that the vaxx bioweapons have been circulating for nearly a year and a half, these honorable scientists have been able to study the real pandemic, the real issue – the Covid injection genocide campaign.
I am asking the reader to go back to grade school and re-study the scientific method, so that you will know the difference between real scientists and media manipulators who want you dead. I am asking you to come off of your neofascist-era Trump derangement, and seek truth and clarity as though your life depends on it. For many of you – it does.
What follows is an annotated bibliography of scientific studies and meta-analyses that prove those of us dismissed by the CIA and their bobble-head followers as “conspiracy theorists” right about the vaxx bioweapon. Note how – unlike elite-controlled media outlets, I am actually showing you real scientific studies.
I. Adverse Events Statistics and Related Studies
10 section entries. Last updated 5/6/22.
VAERS COVID Vaccine Adverse Event Reports
Author: OpenVAERS Date: Last Updated 22 April 2022
Published: Self-published on organizational website
Link: https://openvaers.com/covid-data
OpenVAERS tracks and extracts data from CDC’s Vaccine Adverse Event Reporting System and compiles this data in a user-friendly, unbiased fashion. This is an invaluable service, as CDC has a tendency to hide and misrepresent data—especially when the financial interests of their organization and/or their patrons is at stake, as is the case with COVID-19 vaxx bioweapon products. As of this writing, VAERS has tracked more than 1.2 million adverse events related to the COVID vaxx bioweapons in the United States as of 04/22/2022, including 27,532 deaths and 51,163 permanent disabilities.
COVID vaccination and age-stratified all-cause mortality risk
Author: Spiro Pantazatos and Hervé Seligmann Date: October 2021
Published: Pre-print, available online
This study tracks all-cause mortality rates for localized populations in America and Europe as a function of the introduction of the COVID-19 vaxx bioweapon within the given region. The Columbia University researchers stratified their data analysis by age so as to discover any relationship between age and vaccine-induced fatality rates (VFR). From the abstract: “Vaccination correlated negatively with mortality 6-20 weeks post-injection, while vaccination predicted all-cause mortality 0-5 weeks post-injection in almost all age groups and with an age-related temporal pattern consistent with the US vaccine rollout. Results from fitted regression slopes (p<0.05 FDR corrected) suggest a US national average VFR of 0.04% and higher VFR with age (lower bound estimates of VFR=0.004% in ages 0-17 increasing to 0.06% in ages >75 years), and 146K to 187K vaccine-associated US deaths between February and August, 2021. Notably, adult vaccination increased ulterior mortality of unvaccinated young (<18, US; <15, Europe).”
Electronic Support for Public Health–Vaccine Adverse Event Reporting System (ESP:VAERS)
Author: Ross Lazarus and Harvard Pilgrim Health Care, Inc. Date: 2011
Published: The Agency for Healthcare Research and Quality (AHRQ) of the U.S. Department of Health and Human Services (study published by government agency on its website)
Though published long before the COVID era, researchers point to this study as evidence that under-reporting of vaccine injuries is the rule, not the exception. Lazarus concludes that less than 1% of vaccine injuries are reported to VAERS. If this figure holds true through to the present day, then the 27,349 vaxx deaths reported to VAERS reflects a reality of 2,734,900 vaxx deaths to date (the death figure grows constantly and is already outdated as of 5/3/2022; will leave the original text for illustrative purposes). Those of us who were observing the CDC criminal cabal’s behaviors at the time remember that CDC directly intervened and manipulated these numbers in summer of 2021, taking the entire reporting system down and freezing the figures for weeks. When VAERS relaunched, the numbers of COVID vaxx reactions had magically reduced to less than 50% of the original figures. One can then further stipulate that the 1% figure of 27,349 may itself be an artificially manipulated and reduced.
Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine - United States, March-April 2021
Author: David K. Shay et al. Date: 7 May 2021
Published: Morbidity and Mortality Weekly Report
Link: https://pubmed.ncbi.nlm.nih.gov/33956784/
From the abstract: “Approximately 338,700 Janssen COVID-19 vaccine recipients completed at least one v-safe survey during the week after vaccination; 76% reported a systemic reaction, 61% reported a local reaction, and 34% reported a health impact. Fatigue and pain were commonly reported symptoms in both VAERS and v-safe. The overall safety profile is consistent with preauthorization clinical trials data. Prompt review of U.S. vaccine safety data detected three additional cases of non-CVST TTS, in addition to the previously recognized CVST cases that initiated the pause in use of the Janssen COVID-19 vaccine. Ongoing monitoring of adverse events after COVID-19 vaccination, including vaccination with the Janssen single-dose vaccine, is essential for evaluating the risks and benefits of each vaccine.”
A review of adverse effects of COVID-19 vaccines
Author: Hisham Ahmed Mushtaq et al. Date: 1 March 2022
Published: Infez Med. 2022; 30(1)
Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8929726/
This study examines adverse events to vaxx products circulating, including adenovirus and mRNA products. Specific adverse reactions examined include: thrombosis, Guillain-Barré syndrome, Acute transverse myelitis, myocarditis, pericarditis, cutaneous reactions, and glomerular disease.
Critical Appraisal of VAERS Pharmacovigilance: Is the US Vaccine Adverse Events Reporting System (VAERS) a Functioning Pharmacovigilance System?
Author: Jessica Rose Date: Oct. 2021
Published: Science, Public Health Policy, and the Law
Dr. Peter McCullough discusses this article as evidence that there were ample red flags associated with adverse event reports throughout 2021 that the vaxx bioweapon experiment should have been halted from its very beginning. For those of us who were observing the highly suspicious CDC activities regarding censoring and editing VAERS data as the numbers were snowballing in real time, this study is highly validating in that it measures and analyzes hard data the reflects the reality of these observations – and gives us some sense of the extent of the suspicious interference. From the abstract: “This appraisal assesses three issues that respond to the question of VAERS pharmacovigilance by analyzing VAERS data: 1. deleted reports, 2. delayed entry of reports and 3. recoding of Medical Dictionary for Regulatory Activities (MedDRA) terms from severe to mild. The most recently updated publicly available VAERS dataset was found to have N=1516 (0.4%) VAERS IDs removed (“missing”).”
Analysis of COVID vaccine death reports from the VAERS database
Author: Scott McLachlan et al. Date: June 2021
Published: Pre-print / ResearchGate
This study examined the first 250 vaxx-related deaths reported to VAERS in early 2021. The researchers performed deep-dive analyses on each of these cases and found that vaxx could only be ruled out as a causative factor for 14% of them. From the executive summary: “This interim report presents the results of our analysis of the first 250 reported deaths that have been reviewed and coded by our team. We identified health service employees as the reporter in at least 67% of the reports, while pharmaceutical employees were identified as the reporter in a further 5%. Lay people were identifiable as the reporter in only 28% of the reports. This suggests an intention for clinical applicability and usefulness and goes some way towards addressing the common disclaimer that many VAERS reports are made by aggrieved family members and anti-vaxxers, both with an axe to grind. The sample is heavily biased because these were all people vaccinated very early in the programme when only the elderly, those with significant or chronic health conditions and frontline health service staff were being vaccinated. Yet, our analysis shows that the patients can be grouped into three main types: (i) those where the vaccine was most likely not a factor; (ii) those where the vaccine may have been a factor; and (iii) those where the vaccine was the most likely factor in their deaths.”
Why are we vaccinating children against COVID-19?
Author: Ronald Kostoff et al. Date: 14 Sep. 2021
Published: Toxicology Reports
Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437699/
This study provides a critical analysis of vaxx bioweapon clinical trials and performs a statistics-based cost-benefit analysis, demonstrating that the significantly higher death rate of the vaxx relative to SARS-CoV-2 infection for the 65+ demographic renders the push to inoculate children with these bioweapons clearly illogical and promoted in bad faith. From the abstract: “Clinical trials for these inoculations were very short-term (a few months), had samples not representative of the total population, and for adolescents/children, had poor predictive power because of their small size. Further, the clinical trials did not address changes in biomarkers that could serve as early warning indicators of elevated predisposition to serious diseases. Most importantly, the clinical trials did not address long-term effects that, if serious, would be borne by children/adolescents for potentially decades. A novel best-case scenario cost-benefit analysis showed very conservatively that there are five times the number of deaths attributable to each inoculation vs those attributable to COVID-19 in the most vulnerable 65+ demographic. The risk of death from COVID-19 decreases drastically as age decreases, and the longer-term effects of the inoculations on lower age groups will increase their risk-benefit ratio, perhaps substantially.”
The Global Covid Vaccination Campaign Is Courting Catastrophe
Author: Vasko Kohlmayer Date: 14 Feb. 2022
Published: American Thinker [online magazine]
This is not a research study, but is rather a data-driven reflection article, which aims to ground the reader in the baseline reality of standard operating procedures relative to vaccine research and development, as well as good scientific practice. The author demonstrates that the pro-vaxx propagandists had no legitimate basis to utilize the hypnotic moniker “safe and effective” in their vaxx bioweapon promotional campaigns, as no phase III clinical trials took place prior to worldwide marketing of these products. Essentially, the entire planet was conscripted to phase III clinical trials, without adequate informed consent explaining as much. The author further demonstrates that the “safe and effective” moniker is now known to be undeniably false, as data that even the propagandists concede to be true prove that these are the deadliest “vaccines” in history. Kohlmayer links to a bibliographical listing of over 1,000 research studies that demonstrate the dangers of the vaxx bioweapon products, discussed immediately below.
Covid Vaccine Scientific Proof Lethal
Author: Save Us Now UK Date: 5 January 2022
Published: Online article
Link: https://www.saveusnow.org.uk/covid-vaccine-scientific-proof-lethal/
This is the bibliographical article cited by Kohlmayer, discussed immediately above. Save Us Now UK is an anti-vaxx bioweapon organization that alleges that they have uncovered documentation that the UK government deliberately planned to depopulate the UK citizenry by 55 million people using these vaxx bioweapon products. The authors discuss the basic realities of the vaxx products and their effects, and then list 1,011 research studies (as of 5/6/22) that confirm the various dangers associated with these products – complete with active links.
II. Toxic Vaxx Ingredients, Spike Protein, DNA Poisoning
6 section entries. Last updated 5/6/22.
Scanning & Transmission Electron Microscopy Reveals Graphene & Parasites in CoV-19 Vaccines
Author: Robert O. Young CPC, MSc, DSc, PhD Date: 5 Feb. 2021, last updated 12 Mar. 2022
Published: Self-published online, Dr. Robert Young website
This groundbreaking study gave the world the first comprehensive look at the toxic ingredients inside of the vaxx bioweapon. Young uses various types of microscopy, examining both live blood of vaxx victims and the liquid inside the vials as well. He examines all 4 of the branded vaxx bioweapons distributed within the United States: Pfizer, Moderna, Johnson & Johnson, and AstraZeneca. Young reveals the presence of reduced graphene oxide in all vaxx bioweapons. All of the vaxx weapons contain toxic heavy metals, though the specifics vary between the branded products. Pfizer is found to contain live Trypanosoma cruzi parasites – which are native to South American and associated with AIDS.
Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination
Author: Katharina Röltgen, et al. Date: 24 January 2022
Published: Cell. [Online, open access]
Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786601/
Dr. Robert Malone discusses this article on the March 1, 2022 episode of Tommy’s Podcast on Rumble, available here: https://rumble.com/vw69at-tpc-721-dr.-robert-malone-dr.-peter-mccullough-dr.-steve-kebe-pediatric-pro.html.
Essentially, this paper demonstrates that the mRNA in the vaxx is more durable than previous versions of mRNA technology, including the platform that Malone himself invented and patented. Malone explains that this is due to usage of a synthetic uridine base pair compound in the vaxx version of RNA, which does not degenerate within the system as rapidly as does organic mRNA. Malone explains that the durability within the system of the synthetic uridine as opposed to natural RNA is what causes the prolonged effect of continual spike protein production within the system – as proven by this study, which observed increased spike protein saturation within the system relative to natural infection after 60 days. Malone indicates that it is likely that this effect continues well after 60 days – though asserts that science has not discovered the specific duration as of yet.
Taken in tandem with other research, which demonstrates that the spike protein is in fact toxic – including that produced by the vaxx – this means that spike protein toxicity remains in a significantly higher concentration, as well as a persistent state of increase, compared to natural infection for an extended period of time. In other words, the vaxx reprograms the system to produce spike protein toxicity on a constant basis for at least 60 days and likely longer.
Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine Recipients
Author: Alana F. Ogata et al. Date: 15 February 2022
Published: Clinical Infectious Diseases, Volume 74, Issue 4
Link: https://academic.oup.com/cid/article/74/4/715/6279075
This study demonstrates that the vaxx can produce intact toxic spike protein in previously uninfected recipients. It also demonstrates that vaxx recipients develop antigens and antibodies in the system immediately, with a peak around day 5. The researchers do not stipulate as to the meaning of this, stating, “The clinical relevance of this finding is unknown and should be further explored.” However, independent vaxx researcher and journalist Sunny Lan has suggested that this – including the antigens and antibodies produced – are evidence of active intact spike protein infection in the system, contrary to the advertised immunity mechanism of mRNA vaxx products.
Intracellular Reverse Transcription of Pfizer BioNTech COVID-19 mRNA Vaccine BNT162b2 In Vitro in Human Liver Cell Line
Author: Markus Aldén, et al. Date: 25 February 2022
Published: Current Issues in Molecular Biology, Vol. 44, Issue 3 [Open access online]
Link: https://www.mdpi.com/1467-3045/44/3/73/htm
Dr. Robert Malone has discussed this study on various podcast and independent media appearances. This research demonstrates that the mRNA component of the vaxx bioweapon genetically modifies the human host through processes that take place in the liver. The synthetic, weaponized mRNA converts to DNA in the liver and then matriculates through the system. This effect lasts for at least 60 days post inoculation and likely much longer.
Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) Up to 15 Months Post-Infection
Author: Bruce Patterson et al. Date: 10 Jan. 2022
Published: Frontiers in Immunology
Link: https://pubmed.ncbi.nlm.nih.gov/35082777/
Though not directly focused on the vaxx bioweapon, Dr. Peter McCullough explains on a Feb. 2022 episode of The Patrick Coffin Show (https://rumble.com/vvsfsc-the-truth-about-vaccine-injury-and-death-with-dc.-peter-mccullough.html) that this study demonstrates that toxic spike proteins remain within the system up to 15 months post infection. Taken in tandem with other studies, which demonstrate that the vaxx bioweapon produces toxic spike proteins that are identical to the aerosolized infectant version of the COVID spike protein bioweapon in large quantities, this study would suggest that spike toxicity within the vaxxed is highly durable and likely to cause extensive damage for a lengthy period of time.
Comprehensive investigations revealed consistent pathophysiological alterations after vaccination with COVID-19 vaccines
Author: Jiping Liu et al. Date: 26 Oct. 2021
Published: Cell Discovery – nature.com/celldisc
Link: https://pubmed.ncbi.nlm.nih.gov/34697287/
These researchers found that post-vaxx symptoms are common and are essentially equivalent to COVID infection. They recommend that clinicians practice caution when recommending the vaxx to a wide range of medically vulnerable patients. From the abstract: “Here, we report, besides generation of neutralizing antibodies, consistent alterations in hemoglobin A1c, serum sodium and potassium levels, coagulation profiles, and renal functions in healthy volunteers after vaccination with an inactivated SARS-CoV-2 vaccine. Similar changes had also been reported in COVID-19 patients, suggesting that vaccination mimicked an infection. Single-cell mRNA sequencing (scRNA-seq) of peripheral blood mononuclear cells (PBMCs) before and 28 days after the first inoculation also revealed consistent alterations in gene expression of many different immune cell types.”
III. Thrombosis, Thrombocytopenia, Franken-Clots
13 section entries. Last updated 5/6/22.
COVID-19 Vaccine-Associated Thrombosis With Thrombocytopenia Syndrome (TTS): A Systematic Review and Post Hoc Analysis
Author: Muhammad Usman Hafeez et al. Date: December 2021/January 2022
Published: Clinical and Applied Thrombosis/Hemostasis, Volume 27
Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552386/
This is a post hoc analysis of 25 studies that observed the development of Thrombosis (blood clotting) with Thrombocytopenia Syndrome (TTS) in individuals inoculated with the vaxx. The researchers found the specific D-dimer readings that were the best predictors of ultimate patient death in the analysis. They conclude, “Adenoviral COVID-19 vaccines have been shown to trigger TTS, however, reports of patients having received mRNA COVID-19 vaccines are also present. Healthcare providers are recommended to maintain a high degree of suspicion among individuals who have received the COVID-19 vaccine within the last 4 weeks.” Note: this belies the attempts by corporate media in 2021 to misrepresent the clotting issue as exclusive to the adenovirus J&J and AstraZeneca vaxx products.
Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines
Author: Brit Long, M.D.; Rachel Bridwell, M.D.; and Michael Gottlieb, M.D. Date: Nov. 2021
Published: American Journal of Emergency Medicine, Vol. 49
Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143907/
Although this narrative review study, designed to aid with emergency room preparedness for clinicians, plays to the “adenovirus vaxx only” narrative and uses “rare” to describe TTS incidents, it does demonstrate a clear association between the vaxx and the disease. Incidentally, Dr. Charles Hoffe studied his own patients and found clotting in 62% of those who took any vaxx – suggesting that the “rare” may be a cover-their-asses type of word selection. Of course, not all clotting incidents may be classified as TTS – but they would all be considered to be thrombosis.
Diagnosis and Management of Vaccine-Related Thrombosis following AstraZeneca COVID-19 Vaccination: Guidance Statement from the GTH
Author: Johannes Oldenburg et al. Date: April 2021 (epub), June 2021 (print)
Published: Hamostaseologie, 41(3)
Link: https://pubmed.ncbi.nlm.nih.gov/33822348/
This study examines thrombosis in vaxxed patients, focusing on the AstraZeneca product. The researchers explore specific aspects of vaxx-induced thrombosis, comparing it to heparin-induced thrombosis: “It shares pathophysiological features with heparin-induced thrombocytopenia (HIT) and is referred to as vaccine-induced prothrombotic immune thrombocytopenia (VIPIT).”
Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following Adenovirus Vector COVID-19 Vaccination
Author: Menaka Pai et al. Date: 7 May 2021
Published: Science Table COVID-19 Advisory for Ontario
This review is published by Science Table and advises Canadian doctors on the vaxx-induced thrombosis. From the Lay Summary: “The AstraZeneca/COVISHIELD COVID-19 vaccine appears to be associated with rare cases of serious blood clots, including blood clots in the brain and other critical organs. Similar cases have also been reported following the Janssen/Johnson & Johnson COVID-19 vaccine. These blood clots have two important features: they can occur 4 to 28 days after vaccination, and they are associated with low platelets (tiny blood cells that help form blood clots to stop bleeding). Doctors are calling this “vaccine-induced immune thrombotic thrombocytopenia” (VITT), “vaccine-induced prothrombotic immune thrombocytopenia” (VIPIT), or “thrombotic thrombocytopenic syndrome” (TTS). These blood clots are different from the blood clots most people are familiar with; they are more aggressive and are more likely to cause death or severe disability, even with early diagnosis and treatment.”
Vaccine-induced thrombotic thrombocytopenia: the elusive link between thrombosis and adenovirus-based SARS-CoV-2 vaccines
Author: Rossella Marcucci and Marco Marietta Date: 30 June 2021
Published: Internal and Emergency Medicine, Vol. 16
Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243058/
This is a small-sample study focused on the use of rapid immunoassays when detecting vaxx-related clotting. The researchers conclude that rapid immunoassays should be avoided, and that nonheparin anticoagulants should be preferred for treatment of this condition. From the discussion: “Our results provide further support to show that rapid immunoassays should be avoided in the detection of PF4-specific antibodies in patients with suspected VITT. Therefore, the use of a sensitive, quantitative, immunologic test is strongly recommended, because according to the recently proposed algorithm, nonheparin anticoagulants should be preferred when clinically significant levels of anti-PF4 antibodies are detected.”
US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021
Author: Isaac See, MD, et al. Date: Published online 30 Apr 2021
Published: Journal of the American Medical Association (JAMA), Vol. 325, Issue 24
Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087975/
This study takes an in-depth look at 6 American cases of TTS upon inoculation with the Johnson & Johnson vaxx product. All cases were women under the age of 60, and it is believed that they were the first reported cases of vaxx-related TTS in the US. A distinguishing feature of this study is that it gives an in-depth accounting of the TTS onset symptoms for each case – among other helpful details.
Thrombotic thrombocytopenia associated with COVID-19 infection or vaccination: Possible paths to platelet factor 4 autoimmunity
Author: Michel Goldman and Cédric Hermans Date: Published online 24 May 2021.
Published: PLoS Med, 18(5)
Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8153497/
The authors discuss the role that autoimmunity via platelet factor 4 (PF4) plays in both COVID infection and vaxx infection, as pertains to blood clotting symptoms. From the introduction: “Thrombotic thrombocytopenia mimicking heparin-induced thrombocytopenia has been observed in patients with severe Coronavirus Disease 2019 (COVID-19) or after immunisation with adenoviral vector-based vaccines against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Herein, we discuss the pathogenesis of the autoimmune response to platelet factor 4 (PF4) that underlies these disorders.”
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
Author: Andreas Greinacher, M.D. et al. Date: 9 Apr. 2021
Published: The New England Journal of Medicine (online)
Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095372/
This study takes an in-depth look at 11 cases of post-vaxx thrombotic throbocytopenia. Funded by the German Research Foundation, it is clear that the researchers felt the need to tow a pro-vaxx company line despite their findings. Nine out of 11 cases were women ages 22-49. The study incorporates data from 28 additional patients who tested positive for PF4 antibodies (and thereby clotting).
Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination
Author: Kate-Lynn Muir, D.O., et al. Date: 14 Apr. 2021
Published: The New England Journal of Medicine (online)
Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063883/
This is an in-depth study of a single female patient who became critically ill due to vaxx-induced thrombotic thrombocytopenia after the AstraZeneca vaxx. The woman remained in critical condition as of publication of the study.
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
Author: Nina H. Schultz, M.D., Ph.D., et al. Date: 9 Apr. 2021
Published: The New England Journal of Medicine (online)
Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112568/
From the discussion: “We present five cases of severe venous thromboembolism in unusual sites and concomitant thrombocytopenia that occurred 7 to 10 days after vaccination for Covid-19. Four of the patients had severe cerebral venous thrombosis with intracranial hemorrhage, and the outcome was fatal in three. Thrombotic thrombocytopenic purpura and immune thrombocytopenic purpura were not suspected because of the absence of hemolysis and because of the good response to platelet transfusions, respectively. A common denominator in all five patients was a high level of antibodies to PF4–polyanion complexes. We therefore propose that these cases represent a vaccine-related variant of spontaneous heparin-induced thrombocytopenia that we refer to as vaccine-induced immune thrombotic thrombocytopenia (VITT). All the patients had strikingly high levels of antibodies to PF4–polyanion complexes.”
Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review
Author: Maryam Sharifian-Dorche et al. Date: 15 Sept. 2021
Published: Journal of the Neurological Sciences, Vol. 428
Link: https://pubmed.ncbi.nlm.nih.gov/34365148/
From the results: “Until May 19, we found 877 articles with the searched terms. We found 12 articles, which overall present clinical features of 36 patients with CVST and VITT after the ChAdOx1 nCoV-19 vaccine. Moreover, two articles were noted, which present 13 patients with CVST and VITT after Ad26.COV2 vaccine. The majority of the patients were females. Symptom onset occurred within one week after the first dose of vaccination (Range 4–19 days). Headache was the most common presenting symptom. Intracerebral hemorrhage (ICH) and/or Subarachnoid hemorrhage (SAH) were reported in 49% of the patients.”
Oxford-AstraZeneca COVID-19 vaccine-induced cerebral venous thrombosis and thrombocytopaenia: A missed opportunity for a rapid return of experience
Author: Thomas Geeraerts et al. Date: 24 May 2021
Published: Anaesthesia Critical Care & Pain Medicine, Vol. 40
Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8141689/
This study gives in-depth accounts of two patients who died of cerebral clotting after taking the AstraZeneca vaxx product. From the discussion: “Unfortunately, both patients had unfavourable outcome with refractory intracranial hypertension leading to death.”
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination
Author: Marie Scully, M.D., et al. Date: 16 April 2021
Published: The New England Journal of Medicine (online)
Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112532/
From the results: “In the absence of previous prothrombotic medical conditions, 22 patients presented with acute thrombocytopenia and thrombosis, primarily cerebral venous thrombosis, and 1 patient presented with isolated thrombocytopenia and a hemorrhagic phenotype. All the patients had low or normal fibrinogen levels and elevated d-dimer levels at presentation. No evidence of thrombophilia or causative precipitants was identified. Testing for antibodies to platelet factor 4 (PF4) was positive in 22 patients (with 1 equivocal result) and negative in 1 patient. On the basis of the pathophysiological features observed in these patients, we recommend that treatment with platelet transfusions be avoided because of the risk of progression in thrombotic symptoms and that the administration of a nonheparin anticoagulant agent and intravenous immune globulin be considered for the first occurrence of these symptoms.”
IV. Myocarditis, Pericarditis, Cardiovascular Disease
12 section entries. Last updated 5/6/22.
Deaths associated with newly launched SARS-CoV-2 vaccination
Author: Carolin Edler et al. Date: 17 April 2021
Published: Elsevier / Legal Medicine
Link: https://pubmed.ncbi.nlm.nih.gov/33895650/
This study examines 3 autopsy case studies of cardiovascular disease of elderly patients who died shortly after taking the vaxx. Although the researchers do not assert a causal relationship between the vaxx and these deaths—and note relevant comorbidities in each case—patients died 5, 12, and 2 days post-vaxxination respectively, which would suggest that the vaxx bioweapons contributed to a more rapid decline that would otherwise have occurred. From the abstract: “From our catchment area in northern Germany, we have so far become aware of 22 deaths in connection with vaccination in a 5 week period (range: 0–28 days after vaccination). Three death cases after vaccination with Comirnaty®, which were autopsied at the Institute of Legal Medicine Hamburg, are presented in more detail. All three deceased had severe cardiovascular diseases, among other comorbidities, and died in the context of these pre-existing conditions, while one case developed a COVID-19 pneumonia as cause of death.”
Acute Myocarditis Following COVID-19 mRNA Vaccination in Adults Aged 18 Years or Older
Author: Anthony Simone, MD, et al. Date: Oct. 2021
Published: JAMA Internal Medicine, available online
Link: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2784800
This observational study examines incidents of post-vaxxination acute myocarditis within a single health system. Though highly limited in that it did not perform an experimental intervention to determine incidents of myocarditis beyond the reporting bias issue of testing individuals who sough medical care for cardiovascular symptoms, it nevertheless did detect a pattern of post-vaxx myocarditis for those who selected mRNA vaxx bioweapon injections
SARS-CoV-2 mRNA Vaccination-Associated Myocarditis in Children Ages 12-17: A Stratified National Database Analysis
Author: Tracy Beth Høeg MD, PhD, et al. Date: 30 Aug. 2021
Published: medRxiv preprint
Link: https://www.medrxiv.org/content/10.1101/2021.08.30.21262866v1.full.pdf
This study analyzed data sets from VAERS to assess risk stratification and risk-benefit implications for adolescent myocarditis as a vaxx adverse reaction. From the abstract: “Post-vaccination CAE [cardiac adverse event] rate was highest in young boys aged 12-15 following dose two. For boys 12-17 without medical comorbidities, the likelihood of post vaccination dose two CAE is 162.2 and 94.0/million respectively. This incidence exceeds their expected 120-day COVID-19 hospitalization rate at both moderate (August 21, 2021 rates) and high COVID-19 hospitalization incidence.”
A Report on Myocarditis Adverse Events in the U.S. Vaccine Adverse Events Reporting System (VAERS) in Association with COVID-19 Injectable Biological Products
Author: Jessica Rose PhD, MSc, BSc , Peter A. McCullough MD, MPH Date: 2021
Published: Current Problems in Cardiology (2021). The journal later withdrew the article without publishing a reason. Presumably, the reason is political pressure from pro-vaxx forces (whether internal or external to the journal – likely both) as a punishment for Dr. McCullough’s prominence and clear-eyed/full-throated influence within the vaxx truth movement. The link below is therefore to a journal pre-proof addition published by a vaxx-truth activist organization website.
From the abstract: “Myocarditis rates reported in VAERS were significantly higher in youths between the ages of 13 to 23 (p<0.0001) with ~80% occurring in males. Within 8 weeks of the public offering of COVID-19 products to the 12-15-year-old age group, we found 19 times the expected number of myocarditis cases in the vaccination volunteers over background myocarditis rates for this age group. In addition, a 5-fold increase in myocarditis rate was observed subsequent to dose 2 as opposed to dose 1 in 15-year-old males. A total of 67% of all cases occurred with BNT162b2. Of the total myocarditis AE reports, 6 individuals died (1.1%) and of these, were under 20 years of age - 1 was 13. These findings suggest a markedly higher risk for myocarditis subsequent to COVID-19 injectable product use than for other known vaccines, and this is well above known background rates for myocarditis. COVID-19 injectable products are novel and have a genetic, pathogenic mechanism of action causing uncontrolled expression of SARS-CoV-2 spike protein within human cells. When you combine this fact with the temporal relationship of AE occurrence and reporting, biological plausibility of cause and effect, and the fact that these data are internally and externally consistent with emerging sources of clinical data, it supports a conclusion that the COVID-19 biological products are deterministic for the myocarditis cases observed after injection.”
Risk of myopericarditis following COVID-19 mRNA vaccination in a large integrated health system: a comparison of completeness and timeliness of two methods
Author: Katie Sharff et al. Date: 4 Apr. 2022
Published: Pharmacoepidemiol Drug Safety, 2022
Link: https://pubmed.ncbi.nlm.nih.gov/35404496/
This advances vaxx truth by demonstrating that faulty research methods led to an under-estimation of myopericarditis rates post-vaxx in earlier studies. From the abstract: “We identified additional valid cases of myopericarditis following an mRNA vaccination that would be missed by the VSD's search algorithm, which depends on select hospital discharge diagnosis codes. The true incidence of myopericarditis is markedly higher than the incidence reported to US advisory committees in the fall of 2021. The VSD should validate its search algorithm to improve its sensitivity for myopericarditis.”
Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents
Author: Jenna Schauer et al. Date: 2021
Published: The Journal of Pediatrics, 2021
Link: https://www.jpeds.com/action/showPdf?pii=S0022-3476%2821%2900665-X
From the abstract: “Reports have emerged of myocarditis and pericarditis predominantly after the second dose of the coronavirus disease messenger ribonucleic acid vaccine. We describe 13 patients aged 12-17 years who presented with chest pain within 1 week after their second dose of the Pfizer vaccine and were found to have elevated serum troponin levels and evidence of myopericarditis.”
Catecholamines are the key trigger of mRNA SARS-CoV-2 and mRNA COVID-19 vaccine-induced myocarditis and sudden deaths: a compelling hypothesis supported by epidemiological, anatomopathological, molecular and physiological findings.
Author: Flávio A. Cadegiani, MD, MSc, PhD Date: February 2022
Published: Pre-print, available online
This is essentially an investigative post hoc analysis that seeks to establish a pattern to support the hypothesis that catecholamines are the primary trigger for sudden death and myocarditis in young vaxxed athletes. Catecholamines are hormones produced in response to physical or emotional stress, and include dopamine, adrenaline, and noradrenaline. As these hormones spike during physical activity, and are more abundant in young people, males, and athletes, the researchers theorize that a state of over-production of these hormones is likely related to these sudden death episodes. The researchers found that their analysis supported their theory, and that a hyper-profusion of catecholamines were even found in autopsies of vaxxed athletes around the world. From the abstract: “Epidemiological, autopsies, molecular and physiological findings unanimously and strongly suggest that a ‘hypercatecholinergic’ state is the critical predictor that triggers mRNA COVID-19 vaccine-induced myocarditis and potential increase in sudden deaths among elite athletes.”
Myocarditis after Covid-19 mRNA Vaccination
Author: Amanda K. Verma, Kory J. Lavine, Chieh-Yu Lin Date: 18 Aug. 2021
Published: The New England Journal of Medicine
Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385564/
This brief report details 2 case studies of individuals in their 40s who developed myocarditis within 2 weeks of vaxxination. One was a woman who eventually went on drugs to prevent heart failure but was discharged from care. The other was a man who died while in treatment. Details of their symptomology and disease progression are revealed.
Fulminant myocarditis after the second dose of COVID-19 mRNA vaccination
Author: Akihiro Oka et al. Date: Feb. 2022
Published: Clinical Case Reports / Wiley
Link: https://pubmed.ncbi.nlm.nih.gov/35154722/
This is a case study of a 50-year-old man who developed myocarditis after vaxxination. From the abstract: “Myocarditis is an adverse event associated with coronavirus disease 2019 (COVID-19) mRNA vaccination. A 50-year-old man presented with dyspnea and resting chest pain after receiving the second dose of the COVID-19 mRNA vaccine and developed cardiogenic shock. Fulminant myocarditis was diagnosed by endomyocardial biopsy and treated with intravenous corticosteroids.”
Case Report: acute fulminant myocarditis and cardiogenic shock after mRNA coronavirus disease 2019 vaccination requiring extracorporeal cardiopulmonary resuscitation
Author: Yongwhan Lim et al. Date: 29 Oct. 2021
Published: Frontiers in Cardiovascular Medicine
Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8586196/
This is a case study of severe post-vaxx myocarditis which required CPR intervention. From the abstract: “Here, we report a case of acute fulminant myocarditis and cardiogenic shock after the mRNA COVID-19 vaccination, requiring extracorporeal cardiopulmonary resuscitation. Clinicians should keep in mind the possibility of progression to fulminant myocarditis in patients who presented with suggestive symptoms or signs of myocarditis after the COVID-19 vaccination.”
Myocarditis-induced sudden death after BNT162b2 mRNA COVID-19 Vaccination in Korea: Case Report Focusing on Histopathological Findings
Author: Sangjoon Choi et al. Date: 18 Oct. 2021
Published: Journal of Korean Medical Science
Link: https://pubmed.ncbi.nlm.nih.gov/34664804/
This South Korean study bypassed the political kowtowing and found a causal relationship between the vaxx and myocarditis-related sudden death in this case study of a 22-year-old male who perished within 7 hours of diagnosis. From the abstract: “We present autopsy findings of a 22-year-old man who developed chest pain 5 days after the first dose of the BNT162b2 mRNA vaccine and died 7 hours later. Histological examination of the heart revealed isolated atrial myocarditis, with neutrophil and histiocyte predominance. Immunohistochemical C4d staining revealed scattered single-cell necrosis of myocytes which was not accompanied by inflammatory infiltrates. Extensive contraction band necrosis was observed in the atria and ventricles. There was no evidence of microthrombosis or infection in the heart and other organs. The primary cause of death was determined to be myocarditis, causally-associated with the BNT162b2 vaccine.”
Autopsy Histopathologic Cardiac Findings in Two Adolescents Following the Second COVID-19 Vaccine Dose
Author: James R Gill, Randy Tashjian, Emily Duncanson Date: 14 Feb. 2022
Published: Archives of Pathology & Laboratory Medicine
Link: https://pubmed.ncbi.nlm.nih.gov/35157759/
This study examined the autopsies of 2 teenage boys who died of myocardial injury/sudden death following the Pfizer vaxx bioweapon injections. From the abstract: “The myocardial injury seen in these post-vaccine hearts is different from typical myocarditis and has an appearance most closely resembling a catecholamine-mediated stress (toxic) cardiomyopathy. Understanding that these instances are different from typical myocarditis and that cytokine storm has a known feedback loop with catecholamines may help guide screening and therapy.”